Roche halts lung cancer immunotherapy trial due to latest setback
Roche will halt a trial of a new immunotherapy for lung cancer after the drug failed to show benefits over Merck & Co’s established treatment Keytruda, casting further doubt on the promise of a drug pioneered by the Swiss company.
ENTRADAS POPULARES
Colombia was the deadliest country for environmentalists in 2023
septiembre 11, 2024
Floods inundate northern Vietnam, Typhoon Yagi death toll rises
septiembre 11, 2024
Destin Daniel Cretton in talks to direct ‘Spider-Man 4’
septiembre 11, 2024
TRANSMISIÓN EN VIVO